141 related articles for article (PubMed ID: 30365225)
21. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.
Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897
[TBL] [Abstract][Full Text] [Related]
22. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
[TBL] [Abstract][Full Text] [Related]
23. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
[TBL] [Abstract][Full Text] [Related]
24. Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma.
Yang L; Rong W; Xiao T; Zhang Y; Xu B; Liu Y; Wang L; Wu F; Qi J; Zhao X; Wang H; Han N; Guo S; Wu J; Gao Y; Cheng S
Sci China Life Sci; 2013 Jul; 56(7):638-46. PubMed ID: 23749381
[TBL] [Abstract][Full Text] [Related]
25. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.
Zhou JW; Li Y; Yue LX; Luo CL; Chen Y; Zhang JY
Tumour Biol; 2016 Feb; 37(2):2547-53. PubMed ID: 26386724
[TBL] [Abstract][Full Text] [Related]
26. Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma.
Ha SY; Kim JH; Yang JW; Bae H; Cho HY; Park CK
Pathol Res Pract; 2016 Jul; 212(7):616-21. PubMed ID: 27083241
[TBL] [Abstract][Full Text] [Related]
27. Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of phosphopeptides discovered in a large-scale phosphoproteome analysis of hepatocellular carcinoma.
Lin YT; Chien KY; Wu CC; Chang WY; Chu LJ; Chen MC; Yeh CT; Yu JS
J Proteomics; 2017 Mar; 157():40-51. PubMed ID: 28192239
[TBL] [Abstract][Full Text] [Related]
28. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway.
Zhu M; Li W; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Guo J; Li M
Int J Cancer; 2017 Mar; 140(6):1346-1355. PubMed ID: 27925189
[TBL] [Abstract][Full Text] [Related]
29. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery.
Niu D; Feng H; Chen WN
J Proteomics; 2010 May; 73(7):1283-90. PubMed ID: 20188222
[TBL] [Abstract][Full Text] [Related]
31. Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC-MS/MS.
Zhao X; Wu Y; Duan J; Ma Y; Shen Z; Wei L; Cui X; Zhang J; Xie Y; Liu J
J Proteome Res; 2014 Dec; 13(12):5391-402. PubMed ID: 25265333
[TBL] [Abstract][Full Text] [Related]
32. Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model.
Tong A; Wu L; Lin Q; Lau QC; Zhao X; Li J; Chen P; Chen L; Tang H; Huang C; Wei YQ
Proteomics; 2008 May; 8(10):2012-23. PubMed ID: 18491315
[TBL] [Abstract][Full Text] [Related]
33. Identification of specific protein markers in microdissected hepatocellular carcinoma.
Melle C; Ernst G; Scheibner O; Kaufmann R; Schimmel B; Bleul A; Settmacher U; Hommann M; Claussen U; von Eggeling F
J Proteome Res; 2007 Jan; 6(1):306-15. PubMed ID: 17203974
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of primary hepatocellular carcinoma with single and multiple lesions by iTRAQ-based quantitative proteomics.
Xing X; Huang Y; Wang S; Chi M; Zeng Y; Chen L; Li L; Zeng J; Lin M; Han X; Liu X; Liu J
J Proteomics; 2015 Oct; 128():262-71. PubMed ID: 26300425
[TBL] [Abstract][Full Text] [Related]
35. SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma.
Luo Y; Mok TS; Lin X; Zhang W; Cui Y; Guo J; Chen X; Zhang T; Wang T
Sci Rep; 2017 Jan; 7():41191. PubMed ID: 28117408
[TBL] [Abstract][Full Text] [Related]
36. Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis.
Zhang J; Liang R; Wei J; Ye J; He Q; ChunlingYuan ; Ye J; Li Y; Liu Z; Lin Y
Biomed Res Int; 2018; 2018():5484976. PubMed ID: 30345303
[TBL] [Abstract][Full Text] [Related]
37. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
[TBL] [Abstract][Full Text] [Related]
38. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.
Ahn YH; Shin PM; Oh NR; Park GW; Kim H; Yoo JS
J Proteomics; 2012 Sep; 75(17):5507-15. PubMed ID: 22789673
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of the Golgi proteome of hepatocellular carcinoma with that of the adjacent non-tumor tissues].
Xiao Z; Yi YF; He TT; Li YQ
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):23-6. PubMed ID: 20128964
[TBL] [Abstract][Full Text] [Related]
40. Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.
Megger DA; Bracht T; Kohl M; Ahrens M; Naboulsi W; Weber F; Hoffmann AC; Stephan C; Kuhlmann K; Eisenacher M; Schlaak JF; Baba HA; Meyer HE; Sitek B
Mol Cell Proteomics; 2013 Jul; 12(7):2006-20. PubMed ID: 23462207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
